Retroviral RLI/4-1 BBL and RLI/FLT3L Combination Immunomodulatory Gene Therapy for Glioblastoma
$95,027R01FY2023NSNIH
University Of California, San Francisco, San Francisco CA
Investigators
Linked publications & trials
Paper 39255776Paper 38617333Paper 38417064Paper 38357919Paper 37971886Paper 37382331Paper 36993266Paper 36900311Paper 36865128Paper 36640127
Abstract
PROJECT SUMMARY/ABSTRACT This proposed project is within the scope of R01NS123808. There are no changes to the Project Summary/Narrative of the Parent Award. A brief description of the Parent Grant Specific Aims is provided within the Research and Career Plan.
View original record on NIH RePORTER →